These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8381397)

  • 1. Action of a CD24-specific deglycosylated ricin-A-chain immunotoxin in conventional and novel models of small-cell-lung-cancer xenograft.
    Zangemeister-Wittke U; Lehmann HP; Waibel R; Wawrzynczak EJ; Stahel RA
    Int J Cancer; 1993 Feb; 53(3):521-8. PubMed ID: 8381397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor activity of a blocked ricin immunotoxin with specificity against the cluster-5A antigen associated with human small-cell lung cancer.
    Zangemeister-Wittke U; Collinson AR; Fisch I; Jones RM; Waibel R; Lehman HP; Stahel RA
    Int J Cancer; 1993 Jul; 54(6):1028-35. PubMed ID: 8392978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
    Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH
    Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer.
    Wawrzynczak EJ; Zangemeister-Wittke U; Waibel R; Henry RV; Parnell GD; Cumber AJ; Jones M; Stahel RA
    Br J Cancer; 1992 Aug; 66(2):361-6. PubMed ID: 1323991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID mice.
    Schnell R; Katouzi AA; Linnartz C; Schoen G; Drillich S; Hansmann ML; Schiefer D; Barth S; Zangemeister-Wittke U; Stahel RA; Diehl V; Engert A
    Int J Cancer; 1996 May; 66(4):526-31. PubMed ID: 8635869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
    Derbyshire EJ; Henry RV; Stahel RA; Wawrzynczak EJ
    Br J Cancer; 1992 Sep; 66(3):444-51. PubMed ID: 1325825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.
    Derbyshire EJ; Stahel RA; Wawrzynczak EJ
    Cancer Immunol Immunother; 1992; 35(6):417-20. PubMed ID: 1327529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancer.
    Derbyshire EJ; Wawrzynczak EJ
    Int J Cancer; 1992 Oct; 52(4):624-30. PubMed ID: 1328073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.
    Pearson JW; Fogler WE; Volker K; Riggs CW; Gruys E; Groves ES; Wiltrout RH; Longo DL
    J Natl Cancer Inst; 1993 Jun; 85(11):907-12. PubMed ID: 8492319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin.
    Roy DC; Ouellet S; Le Houillier C; Ariniello PD; Perreault C; Lambert JM
    J Natl Cancer Inst; 1996 Aug; 88(16):1136-45. PubMed ID: 8757193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo cytotoxic efficacy of immunotoxins prepared from anti-CD5 antibody linked to ricin A-chain.
    Rostaing-Capaillon O; Casellas P
    Cancer Immunol Immunother; 1991; 34(1):24-30. PubMed ID: 1722138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer; 1990 Sep; 62(3):410-4. PubMed ID: 2169852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.
    Lynch TJ; Lambert JM; Coral F; Shefner J; Wen P; Blattler WA; Collinson AR; Ariniello PD; Braman G; Cook S; Esseltine D; Elias A; Skarin A; Ritz J
    J Clin Oncol; 1997 Feb; 15(2):723-34. PubMed ID: 9053498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
    Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
    Shah SA; Halloran PM; Ferris CA; Levine BA; Bourret LA; Goldmacher VS; Blättler WA
    Cancer Res; 1993 Mar; 53(6):1360-7. PubMed ID: 7680284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer.
    Epstein C; Lynch T; Shefner J; Wen P; Maxted D; Braman V; Ariniello P; Coral F; Ritz J
    Int J Cancer Suppl; 1994; 8():57-9. PubMed ID: 7515030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.
    Derbyshire EJ; de Leij L; Wawrzynczak EJ
    Br J Cancer; 1993 Jun; 67(6):1242-7. PubMed ID: 8390281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
    Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P
    Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.